Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

NCT00626561 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual.

Conditions

Cervical Cancer
Uterine Cancer

Interventions

DRUG: Bevacizumab
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]